You are now leaving GSK’s website

This link will take you to a non-GSK website. GSK does not recommend, endorse or accept liability for sites controlled by third-parties.

Continue

Go back

Possible side effects of Relvar Ellipta

This page is specifically for patients who have been prescribed Relvar Ellipta. If you are not a patient please return to the public website.

Read patient information leaflet for full list of possible side effects.

Allergic Reactions

Allergic reactions to Relvar Ellipta are rare (they affect less than 1 person in 1000).
If you have any of the following symptoms after taking Relvar Ellipta stop taking this medicine and tell your doctor immediately.

  • skin rash (hives) or redness
  • swelling, sometimes of the face or mouth (angioedema)
  • becoming very wheezy, coughing or having difficulty in breathing
  • suddenly feeling weak or light headed (which may lead to collapse or loss of consciousness)

Immediate breathing difficulties

If your breathing or wheezing gets worse straight after using this medicine, stop using it and get medical help immediately.

Pneumonia (infection of the lung) (common side effect)

Tell your doctor if you have any of the following while taking Relvar Ellipta – they could be symptoms of a lung infection:

  • fever or chills
  • increased mucus production, change in mucus colour
  • increased cough or increased breathing difficulties

Side Effects Questions

What do I do if I get a side effect?

If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in the patient information leaflet. You can also report side effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard. By reporting side effects you can help provide more information on the safety of this medicine. If your breathing or wheezing gets worse straight after using Relvar Ellipta, stop using it and get medical help immediately.

This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get. If you experience any side effects, talk to your doctor, pharmacist or nurse. This includes any side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard .
By reporting side effects you can help provide more information on the safety of this medicine.

Relvar and Ellipta are registered trademarks of the GlaxoSmithKline group of companies